Table 2

 Performance of WHO clinical decision rule for streptococcal pharyngitis in three countries

CountryGABHS + n (%) (95% CI)WHO CDR+ n (%) (95% CI)Sensitivity (95% CI)Specificity (95% CI)PPV (95% CI)NPV (95% CI)
*Statistically significant difference between sites, p⩽0.05.
Age 2–12 years
Brazil (n = 191)47 (24.6) (18.7 to 31.4)10 (5.2) (2.5 to 9.4)8.5 (2.4 to 20.4)95.8 (91.2 to 98.5)45.5 (12.2 to 73.8)76.7 (69.4 to 82.2)
Croatia (n = 200)84 (42.0) (35.1 to 49.2)12 (6.0) (3.1 to 10.2)5.9 (1.9 to 13.4)93.9 (93.9 to 87.9)41.7 (15.2 to 72.3)57.9 (50.6 to 65.1)
Egypt (n = 1419)387 (27.7) (24.9 to 29.7)47 (3.3) (2.4 to 4.4)4.1 (2.4 to 6.6)97.0 (95.7 to 97.9)34.0 (20.9 to 49.3)72.9 (70.5 to 75.3)
p value (χ2 by site)⩽0.001⩽0.0010.3630.2020.855⩽0.001
Age <5 years
Brazil (n = 81)10 (12.4) (6.1 to 21.5)3 (3.7) (0.8 to 10.4)0.0 (0.0 to 30.9)95.7 (88.1 to 99.1)0.0 (0.0 to 70.7)87.2 (77.7 to 93.7)
Croatia (n = 64)28 (43.8) (31.4 to 56.7)3 (4.7) (0.98 to 13.1)3.6 (0.1 to 18.4)94.4 (81.3 to 99.3)33.3 (0.8 to 90.6)55.7 (42.5 to 68.5)
Egypt (n = 749)175 (23.7) (20.4 to 26.6)27 (3.6) (2.4 to 5.2)4.6 (1.9 to 8.8)96.7 (94.9 to 98.0)29.6 (13.8 to 50.2)76.9 (73.6 to 79.9)
p value (χ2 by sites)⩽0.001⩽0.0010.7700.7350.534⩽0.001
Age 5–12 years
Brazil (n = 110)37 (33.6) (24.9 to 43.3)7 (6.3) (2.6 to 12.7)10.8 (3.0 to 25.4)95.9 (88.5 to 99.1)57.1 (18.4 to 90.1)67.9 (58.0 to 76.8)
Croatia (n = 136)56 (41.8) (32.8 to 49.9)9 (6.6) (3.1 to 12.2)7.1 (1.9 to 17.3)93.8 (86.0 to 97.9)44.4 (13.7 to 78.8)59.1 (49.9 to 67.7)
Egypt (n = 670)212 (31.6) (28.1 to 35.3)20 (2.9) (1.8 to 4.6)3.8 (1.6 to 7.3)97.4 (95.5 to 98.6)40.0 (19.1 to 63.9)68.6 (64.9 to 72.2)
p value (χ2 by site)0.0990.0990.1620.2210.7340.109